biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	5E5C7F7C-7850-42F4-AC95-807269580764
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-5R-AAAM-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-5R-AAAM-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-5R-AAAM-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164328
biospecimen__bio__day_of_creation	09
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-5R-AAAM.B07C5DBA-634E-4028-A32D-61FE7445BDEE.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	B
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-5R-AAAM
biospecimen__shared__patient_id	AAAM
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	EBD6C954-E165-46D6-B1A1-57783BCD2C58
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.2
clinical__chol_lihc_shared__albumin_result_specified_value	3.0
clinical__chol_lihc_shared__albumin_result_upper_limit	4.6
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	15
clinical__chol_lihc_shared__fetoprotein_outcome_value	32
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	11
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	15
clinical__chol_lihc_shared__platelet_result_lower_limit	150000
clinical__chol_lihc_shared__platelet_result_upper_limit	450000
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	65
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	68000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	1ea12959-e1d3-4beb-adee-07f5a0f41882
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-5R-AAAM-01A-12R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f712ba82-a830-4395-8e29-ba89e3561ff5
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.71
gdc__analytes__analyte_id	a72a878e-8af8-46fe-9643-9740c3065a7a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	477affb9-7c8b-4895-a4f3-6cc6ef8ec5e4
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	c85b6cc0-77da-54c2-95a0-aa995b0f4d6c
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1948
gdc__demographic__year_of_death	2013
gdc__diagnoses__age_at_diagnosis	24020
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24020.0
gdc__diagnoses__days_to_death	46.0
gdc__diagnoses__diagnosis_id	fd4e97be-9521-54ba-8618-d24fb3e4de8c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	30.110278896458276
gdc__exposures__exposure_id	728f5baa-b624-516b-b133-8ca990e702b3
gdc__exposures__height	163.0
gdc__exposures__weight	80.0
gdc__file_id	e5cd00ea-bbb3-4539-ab50-f998debdee66
gdc__file_name	db9e753d-f9b3-409d-8b18-26c4f8a433c4.mirbase21.mirnas.quantification.txt
gdc__file_size	50318
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	fad665a356937d092e9916b6032b5c33
gdc__portions__is_ffpe	false
gdc__portions__portion_id	9f37c34a-69c5-44a0-ad7a-c9ad5efab1fe
gdc__portions__portion_number	12
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	35
gdc__samples__initial_weight	730.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	B07C5DBA-634E-4028-A32D-61FE7445BDEE
gdc__samples__sample_id	e4e33aac-7fd7-4c43-ae92-c0eb7af07183
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	4.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	50.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	50.0
gdc__slides__percent_tumor_nuclei	60.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	13e28797-ea17-4400-9fbe-7509df2bfe80
gdc__submitter_id	mirna_swap_dr11_79_MirnaExpression7d4358dc-4287-4a57-ad7d-ba50f911343a_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	5R
gdc__tissue_source_site__name	Proteogenex Inc
gdc__tissue_source_site__tissue_source_site_id	9a7a9c39-f289-5594-972a-ff9157a187f0
gdc__treatments__treatment_id	c013192f-ed49-5205-a687-ac6a69c17afc
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:23.029+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1ea12959-e1d3-4beb-adee-07f5a0f41882-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1ea12959-e1d3-4beb-adee-07f5a0f41882-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129689
manually_curated__local_md5	de4bd91c0c325ab670d18cfe2468cd9c
manually_curated__opengdc_download_date	2018-10-16T17:13:11.000156+02:00
manually_curated__opengdc_file_md5	014ade178098a0547bf86850aaf91434
manually_curated__opengdc_file_size	50317
manually_curated__opengdc_id	1ea12959-e1d3-4beb-adee-07f5a0f41882-meq
manually_curated__origin_file_size	129689
manually_curated__origin_last_modified_date	Tue Oct 16 17:50:00 CEST 2018
manually_curated__origin_md5	de4bd91c0c325ab670d18cfe2468cd9c
manually_curated__tissue_status	tumoral
